Please assess the completion status of the following clinical trial:

Trial Title: The Antihypertensives and Vascular, Endothelial and Cognitive Function Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* 60 years or older~* Hypertension~* Cognitive criteria: score either 10 or less out of 15 for the executive clock draw test 1 (CLOX1) or less than or equal to 1 standard deviation from the corresponding age specific mean on the immediate memory subtest~Exclusion Criteria:~* Intolerance to ACEI or ARB~* History of congestive heart failure~* History of diabetes mellitus~* History of stroke (less than 6 months)

- Gender: ALL
- Minimum Age: 60 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Candesartan (Type: EXPERIMENTAL): Angiotensin Receptor Blocker
- Lisinopril (Type: EXPERIMENTAL): Angiotensin-Converting Enzyme (ACE) Inhibitor
- HCTZ (Type: ACTIVE_COMPARATOR): Hydrochlorothiazide (diuretic)

Based on this trial design, predict the completion outcome and termination type (if applicable).